Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-15 02:06 | 2023-11-13 | ASA | ASA Gold and Precious Metals Limited | Saba Capital Management, L.P. | 10% owner | Other | BUY | $13.27 | 152,901 | $2,029,715 | 2,314,612 | +7.1% |
| 2023-11-15 05:00 | 2023-11-10 | TXO | TXO Partners, L.P. | HUTTON KEITH A | Director, Officer, Other - See Remarks | Crude Petroleum & Natural Gas | BUY | $17.60 | 180,000 | $3,168,000 | 3,122,215 | +6.1% |
| 2023-11-15 05:00 | 2023-11-10 | TXO | TXO Partners, L.P. | SIMPSON BOB R | Director, Officer, 10% owner, Other - See Remarks | Crude Petroleum & Natural Gas | BUY | $17.60 | 276,890 | $4,873,264 | 4,400,000 | +6.7% |
| 2023-11-15 00:32 | 2023-11-14 | CRGX | N/A | PERCEPTIVE ADVISORS LLC | Other | Other | BUY | $15.00 | 666,666 | $9,999,990 | 333,333 | +100.0% |
| 2023-11-15 02:36 | 2023-11-13 | NXJ | NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $10.85 | 110,867 | $1,203,284 | 4,607,428 | +2.5% |
| 2023-11-15 00:25 | 2023-11-10 | HHH | Howard Hughes Holdings Inc. | Pershing Square Capital Management, L.P. | Director, 10% owner | Real Estate Investment Trusts | BUY | $71.83 | 159,671 | $11,469,248 | 18,150,574 | +0.9% |
| 2023-11-15 00:16 | 2023-11-13 | MRCY | MERCURY SYSTEMS INC | Carvalho Orlando D | Director | Electronic Components & Accessories | BUY | $33.83 | 35,000 | $1,184,047 | 52,254 | +202.9% |
| 2023-11-15 00:12 | 2023-11-09 | INTC | INTEL CORP | TAN LIP BU | Director | Semiconductors & Related Devices | BUY | $37.84 | 66,000 | $2,497,631 | 166,000 | +66.0% |
| 2023-11-13 21:06 | 2023-11-08 | N/A | N/A | Abu Dhabi Developmental Holding Co PJSC | 10% owner | Other | BUY | $20.00 | 562,302 | $11,246,046 | 576,879 | +3,857.6% |
| 2023-11-13 17:26 | 2023-10-02 | TAKIX | N/A | PRINCIPAL LIFE INSURANCE CO | 10% owner | Other | BUY | $25.00 | 720,000 | $18,000,000 | 720,000 | +100.0% |
| 2023-11-14 03:11 | 2023-11-13 | JANX | Janux Therapeutics, Inc. | Avalon Ventures XI, L.P. | 10% owner | Pharmaceutical Preparations | BUY | $5.87 | 849,854 | $4,988,643 | 849,854 | +100.0% |
| 2023-11-13 18:27 | 2023-11-10 | ACDC | ProFrac Holding Corp. | THRC Holdings, LP | 10% owner | Oil & Gas Field Services, NEC | BUY | $9.63 | 630,496 | $6,071,676 | 72,870,545 | +0.9% |
| 2023-11-13 23:53 | 2023-11-09 | AEVA | Aeva Technologies, Inc. | Sylebra Capital Ltd | 10% owner | Motor Vehicle Parts & Accessories | BUY | $0.58 | 24,795,027 | $14,455,501 | 51,896,560 | +91.5% |
| 2023-11-14 03:01 | 2023-11-08 | NMRA | Neumora Therapeutics, Inc. | Burow Kristina | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.98 | 140,605 | $1,543,562 | 4,096,197 | +3.6% |
| 2023-11-13 18:41 | 2023-11-09 | EMO | ClearBridge Energy Midstream Opportunity Fund Inc. | Saba Capital Management, L.P. | 10% owner | Other | BUY | $31.67 | 38,425 | $1,216,924 | 2,883,023 | +1.4% |
| 2023-11-13 18:38 | 2023-11-09 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.92 | 184,051 | $2,746,630 | 18,621,517 | +1.0% |
| 2023-11-13 18:18 | 2023-11-09 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $13.47 | 321,319 | $4,329,484 | 12,669,877 | +2.6% |
| 2023-11-13 18:16 | 2023-11-09 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $6.76 | 533,682 | $3,605,395 | 33,924,407 | +1.6% |
| 2023-11-13 18:22 | 2023-11-09 | CEM | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $35.54 | 49,208 | $1,749,084 | 2,061,377 | +2.4% |
| 2023-11-14 00:01 | 2023-11-08 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% owner | Services-Prepackaged Software | BUY | $1.82 | 1,014,197 | $1,845,839 | 8,109,222 | +14.3% |
| 2023-11-13 16:23 | 2023-11-09 | OPK | OPKO HEALTH, INC. | FROST PHILLIP MD ET AL | Director, Officer, 10% owner - CEO & Chairman | Pharmaceutical Preparations | BUY | $1.27 | 1,000,000 | $1,266,900 | 201,956,694 | +0.5% |
| 2023-11-13 19:20 | 2023-11-13 | APD | Air Products and Chemicals Inc. | Ghasemi Seifi | Officer - Chairman, Pres. and CEO | Industrial Inorganic Chemicals | BUY | $264.42 | 11,000 | $2,908,620 | 670,673 | +1.7% |
| 2023-11-14 00:05 | 2023-11-08 | TALO | TALOS ENERGY INC. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Crude Petroleum & Natural Gas | BUY | $13.94 | 1,557,411 | $21,704,080 | 14,949,411 | +11.6% |
| 2023-11-14 01:41 | 2023-11-08 | SQ | Block, Inc. | BOTHA ROELOF | Director | Services-Prepackaged Software | BUY | $50.89 | 540,646 | $27,515,097 | 540,646 | +100.0% |
| 2023-11-14 03:00 | 2023-11-08 | NMRA | Neumora Therapeutics, Inc. | ARCH Venture Partners XII, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.98 | 140,605 | $1,543,562 | 4,096,197 | +3.6% |
| 2023-11-13 18:14 | 2023-11-09 | BFZ | BlackRock California Municipal Income Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $10.54 | 128,345 | $1,352,897 | 4,928,088 | +2.7% |
| 2023-11-14 00:27 | 2023-11-13 | CNP | CENTERPOINT ENERGY INC | LESAR DAVID J | Director, Officer - CEO | Electric Services | BUY | $27.12 | 37,000 | $1,003,440 | 37,000 | +100.0% |
| 2023-11-13 19:39 | 2023-11-09 | NXJ | NUVEEN NEW JERSEY QUALITY MUNICIPAL INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $10.83 | 131,575 | $1,424,970 | 4,496,561 | +3.0% |
| 2023-11-13 23:44 | 2023-11-09 | SEDG | SOLAREDGE TECHNOLOGIES, INC. | AVERY MORE | Director | Semiconductors & Related Devices | BUY | $70.96 | 15,300 | $1,085,631 | 70,446 | +27.7% |
| 2023-11-09 23:12 | 2023-11-07 | B | N/A | Manner Hans-Peter | Director | Other | BUY | $22.78 | 50,000 | $1,138,815 | 66,079 | +311.0% |
| 2023-11-10 00:24 | 2023-11-09 | N/A | N/A | INTERCORP PERU LTD | 10% owner | Other | BUY | $20.00 | 482,199 | $9,643,987 | 494,699 | +3,857.6% |
| 2023-11-10 04:33 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Lundbeckfond Invest A/S | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $11.00 | 227,272 | $2,499,992 | 1,835,959 | +14.1% |
| 2023-11-09 19:05 | 2023-11-08 | CXH | MFS INVESTMENT GRADE MUNICIPAL TRUST | Saba Capital Management, L.P. | 10% owner | Other | BUY | $7.79 | 213,246 | $1,661,186 | 694,805 | +44.3% |
| 2023-11-09 18:46 | 2023-11-07 | NQP | NUVEEN PENNSYLVANIA QUALITY MUNICIPAL INCOME FUND | Saba Capital Management, L.P. | 10% owner | Other | BUY | $10.37 | 246,092 | $2,551,605 | 3,988,749 | +6.6% |
| 2023-11-09 18:08 | 2023-11-07 | ECAT | BlackRock ESG Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.93 | 317,084 | $4,735,428 | 18,437,466 | +1.7% |
| 2023-11-09 17:58 | 2023-11-07 | BMEZ | BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $13.73 | 229,450 | $3,151,404 | 12,348,558 | +1.9% |
| 2023-11-09 17:50 | 2023-11-07 | BIGZ | BlackRock Technology & Private Equity Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $6.70 | 1,158,264 | $7,759,326 | 33,390,725 | +3.6% |
| 2023-11-09 17:46 | 2023-11-08 | BCAT | BlackRock Capital Allocation Term Trust | Saba Capital Management, L.P. | 10% owner | Other | BUY | $14.54 | 83,148 | $1,208,972 | 11,381,043 | +0.7% |
| 2023-11-10 01:02 | 2023-11-07 | AURA | Aura Biosciences, Inc. | Johnson David Michael | Director | Biological Products, (No Diagnostic Substances) | BUY | $7.19 | 199,601 | $1,434,991 | 75,000 | +100.0% |
| 2023-11-09 18:04 | 2023-11-07 | CEM | N/A | Saba Capital Management, L.P. | 10% owner | Other | BUY | $35.61 | 98,777 | $3,517,617 | 2,012,169 | +5.2% |
| 2023-11-10 00:35 | 2023-11-09 | AURA | Aura Biosciences, Inc. | Matrix Capital Management Company, LP | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $9.00 | 1,560,000 | $14,040,000 | 6,922,870 | +29.1% |
| 2023-11-10 04:36 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Omega Fund VI, L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $11.00 | 454,545 | $4,999,995 | 2,157,623 | +26.7% |
| 2023-11-09 17:14 | 2023-11-08 | APH | Amphenol Corporation | Livingston Robert | Director | Electronic Connectors | BUY | $84.81 | 11,839 | $1,004,066 | 59,120 | +25.0% |
| 2023-11-10 03:01 | 2023-11-07 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | Ophthalmic Goods | BUY | $33.42 | 289,140 | $9,662,770 | 10,068,017 | +3.0% |
| 2023-11-10 00:00 | 2023-11-07 | ET | Energy Transfer LP | WARREN KELCY L | Director, Officer - Executive Chairman | Natural Gas Transmission | BUY | $13.33 | 1,000,000 | $13,330,000 | 66,578,477 | +1.5% |
| 2023-11-10 04:32 | 2023-11-07 | LXEO | Lexeo Therapeutics, Inc. | Longitude Capital Partners IV, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $11.00 | 454,545 | $4,999,995 | 2,567,100 | +21.5% |
| 2023-11-09 23:20 | 2023-11-09 | N/A | N/A | VEP Group, LLC | 10% owner | Other | BUY | $20.00 | 241,100 | $4,821,993 | 248,600 | +3,214.7% |
| 2023-11-10 00:26 | 2023-11-07 | HHH | Howard Hughes Holdings Inc. | Pershing Square Capital Management, L.P. | Director, 10% owner | Real Estate Investment Trusts | BUY | $72.24 | 190,248 | $13,742,945 | 17,990,903 | +1.1% |
| 2023-11-08 21:40 | 2023-11-07 | N/A | N/A | UAW Chrysler Retirees Medical Benefits Plan | 10% owner | Other | BUY | $10.40 | 4,807,692 | $49,999,997 | 15,121,364 | +46.6% |
| 2023-11-09 02:25 | 2023-11-06 | KDP | Keurig Dr Pepper Inc. | Cofer Timothy P. | Officer - Chief Operating Officer | Beverages | BUY | $31.17 | 100,000 | $3,117,400 | 400,393 | +33.3% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.